BeOne Medicines AG (HKG:6160)

BeOne Medicines AG Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	268,866	261,671	152,765	147,345	178,113	217,115
Market Cap Growth	26.51%	71.29%	3.68%	-17.27%	-17.96%	19.19%
Enterprise Value	240,220	238,190	139,855	128,433	144,042	192,027
Last Close Price	181.00	179.30	109.20	110.10	134.20	161.00
PE Ratio	64.25	117.17	-	-	-	-
PS Ratio	6.01	6.29	5.16	7.67	16.13	23.67
PB Ratio	7.16	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	7.44	7.82	5.99	5.42	5.26	4.58
P/FCF Ratio	29.09	35.70	-	-	-	-
P/OCF Ratio	25.37	29.82	-	-	-	-
EV/Sales Ratio	5.38	5.73	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	36.62	52.87	-	-	-	-
EV/EBIT Ratio	45.86	68.44	-	-	-	-
EV/FCF Ratio	25.99	32.49	-	-	-	-
Debt / Equity Ratio	0.25	0.25	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.40	1.79	-	-	-	-
Debt / FCF Ratio	1.01	1.16	-	-	-	-
Net Debt / Equity Ratio	-0.76	-0.79	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-4.45	-5.97	3.86	2.00	2.28	4.25
Net Debt / FCF Ratio	-3.10	-3.67	2.44	1.30	2.16	3.80
Asset Turnover	-	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	-	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.26	2.97	1.51	1.97	3.22	4.45
Current Ratio	3.73	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	-	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	-	3.96%	-6.06%	-12.39%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	54.41%	22.87%	-36.89%	-138.75%	-549.14%	-
Return on Capital Employed (ROCE)	10.10%	7.00%	-15.30%	-30.20%	-36.40%	-20.70%
Earnings Yield	1.56%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	3.44%	2.80%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.